March 23, 2023

The Spring 2023 advocacy blog Considering Clinical Trials is now available

March 21, 2023

In this video interview, Dr. Neha Vapiwala discusses the INDICATE (EA8191) trial and changing the trajectory of prostate cancer through radiation and imaging techniques

December 20, 2022

The November/December 2022 News from ECOG-ACRIN blog is now available

December 13, 2022

HealthDay News informs the public of the 12-year TAILORx results

December 13, 2022

Press Release: Practice-changing trial results for acute lymphoblastic leukemia (ALL)

December 11, 2022

Press Release: A unique clinical trial leads to a dramatic decrease in early deaths from the rare and aggressiveā€”yet highly curableā€”acute promyelocytic leukemia (APL)

December 6, 2022

Press Release: The TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and survival outcomes

October 28, 2022

Press Release: NCI Director Monica Bertagnolli delivers her first public speech at the ECOG-ACRIN Cancer Research Group meeting

October 26, 2022

Press Release: NCI-MATCH cancer trial finds a promising signal for the AKT inhibitor ipatasertib

ECOG-ACRIN Cancer Research Group